| PERIOD ENDING | 28-Dec-08 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 765,716 | 1,596,387 | 1,091,553 | | Cost of Revenue | 424,719 | 1,048,005 | 631,328 | | | Gross Profit | 340,997 | 548,382 | 460,225 | | | Operating Expenses | | Research Development | 193,522 | 187,803 | 244,104 | | Selling General and Administrative | 248,579 | 298,693 | 187,552 | | Non Recurring | 362,934 | 13,274 | (14,241) | | Others | 5,830 | 36,441 | 15,873 | | | | Total Operating Expenses | 810,865 | 536,211 | 433,288 | | | | Operating Income or Loss | (469,868) | 12,171 | 26,937 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,976 | 396,933 | 35,112 | | Earnings Before Interest And Taxes | (449,892) | 409,104 | 62,049 | | Interest Expense | 4,625 | 10,827 | 9,339 | | Income Before Tax | (454,517) | 398,277 | 52,710 | | Income Tax Expense | 7,929 | (314) | 6,859 | | Minority Interest | 310 | (4,291) | (6,369) | | | | Net Income From Continuing Ops | (462,136) | 394,300 | 39,482 | | | Non-recurring Events | | Discontinued Operations | 31,885 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (430,251) | 394,300 | 39,482 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($430,251) | $394,300 | $39,482 |
|
1.48% Nasdaq 
Income Statement
